SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein (original) (raw)

References

  1. Lendon, C. L., Ashall, F. & Goate, A. M. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277, 825– 831 (1997).
    Article CAS Google Scholar
  2. Mattson, M. P. Cellular actions of beta–amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081–1132 (1997).
    Article CAS Google Scholar
  3. Smith, M. A. et al. Amyloid–beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 2212–2215 (1998).
    Article CAS Google Scholar
  4. Hensley, K. et al. A model for beta–amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270– 3274 (1994).
    Article CAS Google Scholar
  5. Yan, S. D. et al. RAGE and amyloid–beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685– 691 (1996).
    Article CAS Google Scholar
  6. Behl, C., Davis, J. B., Lesley, R. & Schubert, D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817–827 (1994).
    Article CAS Google Scholar
  7. Thomas, T., Thomas, G., McLendon, C., Sutton, T. & Mullan, M. β–amyloid–mediated vasoactivity and vascular endothelial damage. Nature 380, 168–171 (1996).
    Article CAS Google Scholar
  8. Thomas, T., McLendon, C., Sutton, E. T. & Thomas, G. Cerebrovascular endothelial dysfunction mediated by beta–amyloid. Neuroreport 8, 1387–1391 (1997).
    Article CAS Google Scholar
  9. Crawford, F., Suo, Z., Fang, C. & Mullan, M. Characteristics of the in vitro vasoactivity of beta–amyloid peptides. Exp. Neurol. 150, 159–168 ( 1998).
    Article CAS Google Scholar
  10. Blanc, E. M., Toborek, M., Mark, R. J., Hennig, B. & Mattson, M. P. Amyloid beta–peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870–1881 (1997).
    Article CAS Google Scholar
  11. Hsiao, K. K. et al. Age–related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203–1218 ( 1995).
    Article CAS Google Scholar
  12. Wong, P. C. et al. An adverse property of a familial ALS–linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
    Article CAS Google Scholar
  13. Sobey, C. G. & Faraci, F. M. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28, 837–843 ( 1997).
    Article CAS Google Scholar
  14. Rosenblum, W. I., McDonald, M. & Wormley, B. Calcium ionophore and acetylcholine dilate arterioles on the mouse brain by different mechanisms. Stroke 20, 1391–1395 (1989).
    Article CAS Google Scholar
  15. Rosenblum, W. I. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 17, 494–497 (1986).
    Article CAS Google Scholar
  16. Sobey, C. G., Heistad, D. D. & Faraci, F. M. Mechanisms of bradykinin–induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke 28, 2290–2294 ( 1997).
    Article CAS Google Scholar
  17. Mayhan, W. G. Role of activation of bradykinin B2 receptors in disruption of the blood–brain barrier during acute hypertension. Brain Res. 738, 337–341 (1996).
    Article CAS Google Scholar
  18. Rosenblum, W. I. & Nelson, G. H. Endothelium dependence of dilation of pial arterioles in mouse brain by calcium ionophore. Stroke 19, 1379–1382 (1988).
    Article CAS Google Scholar
  19. Wang, Q., Pelligrino, D. A., Koenig, H. M. & Albrecht, R. F. The role of endothelium and nitric oxide in rat arteriolar dilatory responses to CO2 in vivo. J. Cereb. Blood Flow Metab. 14, 944–951 (1994).
    Article CAS Google Scholar
  20. Faraci, F. M., Williams, J. K., Breese, K. R., Armstrong, M. L. & Heistad, D. D. Atherosclerosis potentiates constrictor responses of cerebral and ocular blood vessels to thromboxane in monkeys. Stroke 20, 242– 247 (1989).
    Article CAS Google Scholar
  21. Mayhan, W. G., Faraci, F. M. & Heistad, D. D. Responses of cerebral arterioles to adenosine 5´–diphosphate, serotonin, and the thromboxane analogue U–46619 during chronic hypertension. Hypertension 12, 556–561 (1988).
    Article CAS Google Scholar
  22. Carlson, G. A. et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet. 6, 1951–1959 ( 1997).
    Article CAS Google Scholar
  23. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99– 102 (1996).
    Article CAS Google Scholar
  24. Stamler, J. S. A radical vascular connection. Nature 380, 108–111 (1996).
    CAS PubMed Google Scholar
  25. Mohazzab, K. M., Kaminski, P. M. & Wolin, M. S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266, H2568–2572 (1994).
    CAS PubMed Google Scholar
  26. Wang, P. et al. Overexpression of human copper, zinc–superoxide dismutase (SOD1) prevents postischemic injury. Proc. Natl. Acad. Sci. USA 95, 4556–4560 ( 1998).
    Article CAS Google Scholar
  27. Yang, S. T., Mayhan, W. G., Faraci, F. M. & Heistad, D. D. Endothelium–dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 17, 612– 618 (1991).
    Article CAS Google Scholar
  28. Wei, E. P., Kontos, H. A., Christman, C. W., DeWitt, D. S. & Povlishock, J. T. Superoxide generation and reversal of acetylcholine–induced cerebral arteriolar dilation after acute hypertension. Circ. Res. 57, 781– 787 (1985).
    Article CAS Google Scholar
  29. Mayhan, W. G. Impairment of endothelium–dependent dilatation of basilar artery during chronic hypertension. Am. J. Physiol. 259, H1455–1462 (1990).
    CAS PubMed Google Scholar
  30. Sobey, C. G., Faraci, F. M., Piegors, D. J. & Heistad, D. D. Effect of short–term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke 27, 927–933 (1996).
    Article CAS Google Scholar
  31. Faraci, F. M. & Heistad, D. D. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol. Rev. 78, 53–97 (1998).
    Article CAS Google Scholar
  32. Zhang, F., Eckman, C., Younkin, S., Hsiao, K. K. & Iadecola, C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J. Neurosci. 17, 7655–7661 (1997).
    Article CAS Google Scholar
  33. Mentis, M. J. et al. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153, 32–40 ( 1996).
    Article CAS Google Scholar
  34. Jagust, W. J., Eberling, J. L., Reed, B. R., Mathis, C. A. & Budinger, T. F. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. NY Acad. Sci. 826, 254–262 (1997).
    Article CAS Google Scholar
  35. Hock, C. et al. Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near–infrared spectroscopy (NIRS)—correlation with simultaneous rCBF–PET measurements. Brain Res. 755, 293–303 (1997).
    Article CAS Google Scholar
  36. Warkentin, S. & Passant, U. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test. Dement. Geriatr. Cogn. Disord. 8, 105–109 ( 1997).
    Article CAS Google Scholar
  37. Hatake, K., Kakishita, E., Wakabayashi, I., Sakiyama, N. & Hishida, S. Effect of aging on endothelium–dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 21, 1039–1043 (1990).
    Article CAS Google Scholar
  38. Mayhan, W. G., Faraci, F. M., Baumbach, G. L. & Heistad, D. D. Effects of aging on responses of cerebral arterioles. Am. J. Physiol. H1138–1143 (1990).
  39. Johnson, K.A. et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50, 1563–1571 (1998).
    Article CAS Google Scholar
  40. Sano, M. et al. A controlled trial of selegiline, alpha–tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336, 1216– 1222 (1997).
    Article CAS Google Scholar
  41. Scott, M. R., Kohler, R., Foster, D. & Prusiner, S. B. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1, 986–997 ( 1992).
    Article CAS Google Scholar
  42. Harris, E. D. Copper as a cofactor and regulator of copper, zinc superoxide dismutase. J. Nutr. 122, 636–640 ( 1992).
    Article CAS Google Scholar
  43. Multhaup, G. et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406–1409 (1996).
    Article CAS Google Scholar
  44. Nebot, C. et al. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal. Biochem. 214, 442–451 ( 1993).
    Article CAS Google Scholar
  45. Iadecola, C. & Reis, D. J. Continuous monitoring of cerebrocortical blood flow during stimulation of the cerebellar fastigial nucleus: A study by laser–doppler flowmetry. J. Cereb. Blood Flow Metab. 10, 608–617 (1990).
    Article CAS Google Scholar
  46. Zhang, F., Slungaard, A., Vercellotti, G. M. & Iadecola, C. Superoxide–dependent cerebrovascular effects of homocysteine. Am. J. Physiol. 274, R1704–1711 (1998).
    CAS PubMed Google Scholar

Download references